Read article – Alan Budney, professor of psychiatry, is quoted in an article about new research that suggests that “long-term exposure” to the active compound in marijuana could affect the way brain cells are implicated in addiction. “We’ve known marijuana can lead to an addiction in some people, and we know that it happens because marijuana stimulates dopamine production and makes you feel good,” says Budney. “In terms of demonstrating that it can be addictive, we’re beyond that already.”

Read article – Gilbert Fanciullo, an active emeritus professor of anesthesiology who is also board certified in pain medicine and hospice and palliative care, is quoted about the positive effects that marijuana can have for people suffering from pain. In particular, Fanciullo noted the value medical marijuana can have as a substitute for opioids.

Read article – A feature story about medical student and athlete Luke Mayer ’20, who was diagnosed a rare type of eye cancer and has his right eye removed as a child. Meyer was recently selected to play for Team Louisville Slugger at the Men’s Senior Baseball League’s World Series in Arizona. The team’s roster is comprised of players with physical disabilities.

Read article – Quotes Brian Sites, professor of anesthesiology and of orthopaedics, about a study he coauthored that found that Americans suffering from mental health disorders—16 percent of the population—are receiving more than half of all prescribed opioids.

Read article – An opinion piece by Jonathan Lichtenstein, assistant professor of psychiatry and assistant professor of the Dartmouth Institute for Health Policy and Clinical Practice, in which he discusses Chronic Traumatic Encephalopathy (CTE), and how some medical research has suggested that CTE is the result of concussions or repeated hits to the heads of athletes, namely football players.

Read article – Quotes John Naslund, a PhD student in health policy at the Dartmouth Institute for Health Policy and Clinical Practice, in an article about the impact social media can have on young people’s mental health.

Read article – Quotes Steven Woloshin, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, about a study he conducted that found more than half of the post-approval studies required by the FDA in 2009 and 2010 were either delayed or had not yet started as of 2015. “Unfortunately, we do not have any example of where the FDA has actually imposed a fine or rescinded approval,” says Woloshin. “We know that there have been a few warning letters written to companies that haven’t fulfilled their requirements, but the FDA, as far as we can tell, has never actually imposed a fine or revoked approval for a drug because the post-marketing studies have not been completed.”

Read article – Quotes Alison Holmes, professor of pediatrics, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, about the positive impact of PATHways—an innovative, new program housed in a small University of Kentucky HealthCare clinic that provides both prenatal and addiction care to mothers with substance use disorders.